ARTICLE | Company News
RXi Pharmaceuticals, UMMS deal
January 25, 2010 8:00 AM UTC
RXi and the university will explore the application of RXi's sd-rxRNA compounds for ocular diseases such as age-related macular degeneration (AMD). The parties will use preclinical models of ocular di...